Join our community of smart investors

Watching for a re-entry point into sold-off US tech

Apple and Nvidia are two quality stalwarts and pharma giant Merck has defensive attributes.
Watching for a re-entry point into sold-off US tech
  • Valuations aren't what they were but the macro environment is still challenging
  • Now is the time to build watchlists of quality companies to own when they get cheap enough

All three stocks flagged by our screens scored full marks on our quality tests, which looks for companies able to generate and sustain a high return on capital while reinvesting profits. With the sell-off in US stocks and rising likelihood of recession impacting earnings, we consider whether these mega-cap stocks are still worth a look. 

Nvidia (US:NVDA)  – The chipmaker has been beaten down on a range of headwinds, but could the stock now at last look compelling on a valuation basis given its flawless execution of late?  

To continue reading...
Subscribe to Alpha Today and You’ll Get
  • Unlimited access to all of our content
  • The Analyst's round up of companies and updates on his Fantasy Sipp portfolio
  • Broker style company research notes from our small cap expert Simon Thompson
  • Quality, Momentum, Growth at Reasonable Price (GARP) and Dividend Yield stock screens
  • Algy Hall’s monthly value-momentum investment trust screen and portfolio of diverse closed-end funds
Have an account? Sign in